• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Akila N. Viswanathan, MD, MPH


  • Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W, Gaffney DK.
    NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer.
    Cancer. 2015 Apr 6.
  • Damato AL, Cormack RA, Viswanathan AN.
    A novel intracavitary applicator design for the treatment of deep vaginal fornices: preliminary dose metrics and geometric analysis.
    J Contemp Brachytherapy. 2015 Feb;7(1):48-54.
  • Aviki EM, Esselen KM, Barcia SM, Nucci MR, Horowitz NS, Feltmate CM, Berkowitz RS, Orgill DG, Viswanathan AN, Muto MG.
    Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva?.
    Gynecol Oncol. 2015 Apr;137(1):60-5.
  • Petereit DG, Frank SJ, Viswanathan AN, Erickson B, Eifel P, Nguyen PL, Wazer DE.
    Brachytherapy: where has it gone?.
    J Clin Oncol. 2015 Mar 20;33(9):980-2.
  • Viswanathan AN, Erickson B.
    Seeing is saving: The benefit of 3D imaging in gynecologic brachytherapy.
    Gynecol Oncol. 2015 Mar 4.
  • Damato AL, Lee LJ, Bhagwat MS, Buzurovic I, Cormack RA, Finucane S, Hansen JL, O'Farrell DA, Offiong A, Randall U, Friesen S, Viswanathan AN.
    Redesign of process map to increase efficiency: Reducing procedure time in cervical cancer brachytherapy.
    Brachytherapy. 2015 Jan 6.
  • Tanderup K, Viswanathan AN, Kirisits C, Frank SJ.
    Magnetic Resonance Image Guided Brachytherapy.
    Semin Radiat Oncol. 2014 Jul;24(3):181-191.
  • Damato AL, Townamchai K, Albert M, Bair RJ, Cormack RA, Jang J, Kovacs A, Lee LJ, Mak KS, Mirabeau-Beale KL, Mouw KW, Phillips JG, Pretz JL, Russo AL, Lewis JH, Viswanathan AN.
    Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy.
    Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):674-81.
  • Mayr NA, Hu KS, Liao Z, Viswanathan AN, Wall TJ, Amendola BE, Calaguas MJ, Palta JR, Yue NJ, Rengan R, Williams TR.
    International Outreach: What Is the Responsibility of ASTRO and the Major International Radiation Oncology Societies?.
    Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):481-484.
  • Wang W, Dumoulin CL, Viswanathan AN, Tse ZT, Mehrtash A, Loew W, Norton I, Tokuda J, Seethamraju RT, Kapur T, Damato AL, Cormack RA, Schmidt EJ.
    Real-time active MR-tracking of metallic stylets in MR-guided radiation therapy.
    Magn Reson Med. 2014 Jun 5.
  • Mirabeau-Beale KL, Viswanathan AN.
    Quality of life (QOL) in women treated for gynecologic malignancies with radiation therapy: A literature review of patient - reported outcomes.
    Gynecol Oncol. 2014 May 15.
  • Townamchai K, Poorvu PD, Damato AL, DeMaria R, Lee LJ, Berlin S, Feltmate C, Viswanathan AN.
    Radiation dose escalation using intensity modulated radiation therapy for gross unresected node-positive endometrial cancer.
    Practical Radiation Oncology.;4(2):90-8.
  • Prescott J, Bao Y, Viswanathan AN, Giovannucci EL, Hankinson SE, De Vivo I.
    Dietary insulin index and insulin load in relation to endometrial cancer risk in the Nurses' Health Study.
    Cancer Epidemiol Biomarkers Prev. 2014 May 23.
  • Gaffney DK, Jhingran A, Portelance L, Viswanathan A, Schefter T, Weidhaas J, Small W.
    Radiation therapy oncology group gynecologic oncology working group: comprehensive results.
    Int J Gynecol Cancer. 2014 Jun;24(5):956-62.
  • Klopp A, Smith BD, Alektiar K, Cabrera A, Damato AL, Erickson B, Fleming G, Gaffney D, Greven K, Lu K, Miller D, Moore D, Petereit D, Schefter T, Small W, Yashar C, Viswanathan AN.
    The role of postoperative radiation therapy for endometrial cancer: Executive Summary of an American Society for Radiation Oncology evidence-based guideline.
    Practical Radiation Oncology.;4(3):137-44.
  • Pernelle G, Mehrtash A, Barber L, Damato A, Wang W, Seethamraju RT, Schmidt E, Cormack RA, Wells W, Viswanathan A, Kapur T.
    Validation of catheter segmentation for MR-guided gynecologic cancer brachytherapy.
    Med Image Comput Comput Assist Interv. 2013;16(Pt 3):380-7.
  • Lee LJ, Demaria R, Berkowitz R, Matulonis U, Viswanathan AN.
    Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen.
    Gynecol Oncol. 2014 Jan;132(1):65-9.
  • Viswanathan AN, Lee H, Berkowitz R, Berlin S, Campos S, Feltmate C, Horowitz N, Muto M, Sadow CA, Matulonis U.
    A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer.
    Gynecol Oncol. 2014 Jan;132(1):55-60.
  • Damato AL, Cormack RA, Viswanathan AN.
    Characterization of implant displacement and deformation in gynecologic interstitial brachytherapy.
  • Buyyounouski MK, Viswanathan AN, Prestidge BR, .
    Examining the evidence in pursuit of the highest possible brachytherapy standards.
  • Han K, Milosevic M, Fyles A, Viswanathan AN.
    In reply to Smith and Eifel.
    Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):460-1.
  • Golden DW, Spektor A, Rudra S, Ranck MC, Krishnan MS, Jimenez RB, Viswanathan AN, Koshy M, Howard AR, Chmura SJ.
    Radiation oncology medical student clerkship: implementation and evaluation of a bi-institutional pilot curriculum.
    Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):45-50.
  • Viswanathan AN, Damato AL, Nguyen PL.
    Novel use of a hydrogel spacer permits reirradiation in otherwise incurable recurrent gynecologic cancers.
    J Clin Oncol. 2013 Dec 1;31(34):e446-7.
  • Lee LJ, Damato AL, Viswanathan AN.
    Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer.
    Gynecol Oncol. 2013 Dec;131(3):586-92.
  • Dizon DS, Ambrosio AJ, Feltmate C, Wright AA, Campos SM, Viswanathan A, .
    Pushing the bar in treatment of cervical cancer: what can comprehensive cancer centers do on their own?.
    Gynecol Oncol. 2013 Nov;131(2):464-6.
  • Damato AL, Viswanathan AN, Cormack RA.
    Validation of mathematical models for the prediction of organs-at-risk dosimetric metrics in high-dose-rate gynecologic interstitial brachytherapy.
    Med Phys. 2013 Oct;40(10):101711.
  • Viswanathan AN, Pinto AP, Schultz D, Berkowitz R, Crum CP.
    Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma.
    Gynecol Oncol. 2013 Sep;130(3):545-9.
  • Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan AN.
    Trends in the utilization of brachytherapy in cervical cancer in the United States.
    Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):111-9.
  • Miyamoto DT, Viswanathan AN.
    Concurrent chemoradiation for vaginal cancer.
    PLoS ONE. 2013;8(6):e65048.
  • Viswanathan AN, Szymonifka J, Tempany-Afdhal CM, O'Farrell DA, Cormack RA.
    A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapy.
  • Townamchai K, Berkowitz R, Bhagwat M, Damato AL, Friesen S, Lee LJ, Matulonis U, O'Farrell D, Viswanathan AN.
    Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer.
    Gynecol Oncol. 2013 Apr;129(1):18-21.
  • Poorvu PD, Sadow CA, Townamchai K, Damato AL, Viswanathan AN.
    Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
    Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1262-8.
  • Lee LJ, Damato AL, Viswanathan AN.
    Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance.
    Brachytherapy. 2013 Mar 12.
  • Lee LJ, Viswanathan AN.
    Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
    Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1192-7.
  • Townamchai K, Lee L, Viswanathan AN.
    A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer.
    Gynecol Oncol. 2012 Nov;127(2):351-5.
  • Kapur T, Egger J, Damato A, Schmidt EJ, Viswanathan AN.
    3-T MR-guided brachytherapy for gynecologic malignancies.
    Magn Reson Imaging. 2012 Nov;30(9):1279-90.
  • Lee LJ, Viswanathan AN.
    Combined chemotherapy and radiation improves survival for node-positive endometrial cancer.
    Gynecol Oncol. 2012 Oct;127(1):32-7.
  • Gay HA, Barthold HJ, O'Meara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H, Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Small W, Gaffney D, Viswanathan AN, Michalski JM.
    Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas.
    Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e353-62.
  • Viswanathan AN, Thomadsen B, .
    American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles.
  • Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B.
    American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy.
  • Lee LJ, Das IJ, Higgins SA, Jhingran A, Small W, Thomadsen B, Viswanathan AN, Wolfson A, Eifel P.
    American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy.
  • Beriwal S, Demanes DJ, Erickson B, Jones E, De Los Santos JF, Cormack RA, Yashar C, Rownd JJ, Viswanathan AN.
    American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer.
  • Small W, Beriwal S, Demanes DJ, Dusenbery KE, Eifel P, Erickson B, Jones E, Rownd JJ, De Los Santos JF, Viswanathan AN, Gaffney D.
    American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy.
  • Viswanathan AN.
    Advances in the use of radiation for gynecologic cancers.
    Hematol Oncol Clin North Am. 2012 Feb;26(1):157-68.
  • Viswanathan AN, Moughan J, Small W, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DK.
    The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128.
    Int J Gynecol Cancer. 2012 Jan;22(1):123-31.
  • Viswanathan AN, Macklin EA, Berkowitz R, Matulonis U.
    The importance of chemotherapy and radiation in uterine papillary serous carcinoma.
    Gynecol Oncol. 2011 Sep 30.
  • Viswanathan AN, Creutzberg CL, Craighead P, McCormack M, Toita T, Narayan K, Reed N, Long H, Kim HJ, Marth C, Lindegaard JC, Cerrotta A, Small W, Trimble E.
    International Brachytherapy Practice Patterns: A Survey of the Gynecologic Cancer Intergroup (GCIG).
    Int J Radiat Oncol Biol Phys. 2010 Dec 22.
  • Holloway CL, Macklin EA, Cormack RA, Viswanathan AN.
    Should the organs at risk be contoured in vaginal cuff brachytherapy?.
    Brachytherapy. 2010 Dec 28.
  • Lim K, Small W, Portelance L, Creutzberg C, J├╝rgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A, .
    Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer.
    Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):348-55.
  • Mak RH, Halasz LM, Tanaka CK, Ancukiewicz M, Schultz DJ, Russell AH, Viswanathan AN.
    Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3-4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva.
    Gynecol Oncol. 2011 Jan;120(1):101-7.
  • Viswanathan AN.
    Childhood cancer survivors: stillbirth and neonatal death.
    Lancet. 2010 Aug 21;376(9741):570-2.
  • Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU.
    Radiation dose-volume effects of the urinary bladder.
    Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S116-22. Review.
  • Chang MC, Nevadunsky NS, Viswanathan AN, Crum CP, Feltmate CM.
    Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survival.
    Int J Gynecol Pathol. 2010 Jan;29(1):88-92.
  • Viswanathan AN, Erickson BA.
    Three-Dimensional Imaging in Gynecologic Brachytherapy: A Survey of the American Brachytherapy Society.
    Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):104-9.
  • Viswanathan AN, Cormack R, Rawal B, Lee H.
    Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage IIIB cervical cancer.
    Int J Gynecol Cancer. 2009 Nov;19(8):1402-6.
  • Holloway CL, Racine ML, Cormack RA, O'Farrell DA, Viswanathan AN.
    Sigmoid dose using 3D imaging in cervical-cancer brachytherapy.
    Radiother Oncol. 2009 Nov;93(2):307-10.
  • Lee LJ,Sadow CA,Russell A,Viswanathan AN.
    Correlation of Point B and Lymph Node Dose in 3D-Planned High-Dose-Rate Cervical Cancer Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):803-9.
  • Racine ML, Holloway CL, Cormack RA, O'Farrell DA, Viswanathan AN.
    Dosimetric Analysis of 3D Image-Guided Cervical Cancer Low-dose-rate Tandem and Ovoid and Interstitial Brachytherapy.
  • Viswanathan AN,Schernhammer ES.
    Circulating melatonin and the risk of breast and endometrial cancer in women.
    Cancer Lett. 2009 Aug 18;281(1):1-7. Review.
  • Wo JY,Viswanathan AN.
    Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients.
    Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1304-12. Review.
  • Lin MC,Burkholder KA,Viswanathan AN,Neuberg D,Mutter GL.
    Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms.
    Cancer. 2009 May 15;115(10):2111-8.
  • Stewart AJ, Cormack RA, Lee H, Xiong L, Hansen JL, O'Farrell DA, Viswanathan AN.
    Prospective Clinical Trial of Bladder Filling and Three-Dimensional Dosimetry in High-Dose-Rate Vaginal Cuff Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):843-8.
  • Viswanathan AN, Buttin BM, Kennedy AM.
    Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancer.
    Radiographics. 2008 Jan-Feb;28(1):289-307.
  • Viswanathan AN, Feskanich D, Schernhammer ES, Hankinson SE.
    Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer.
    Cancer Res. 2008 Apr 1;68(7):2507-13.
  • Haglund KE, Viswanathan AN.
    Computed Tomography-Based Radiation Therapy of Ovarian Remnants for Symptomatic Persistent Endometriosis.
    Obstet Gynecol. 2008 Feb;111(2):579-583.
  • Viswanathan AN.
    The Frank Ellis Memorial Lecture: the Use of Three-dimensional Imaging in Gynaecological Radiation Therapy.
    Clin Oncol (R Coll Radiol). 2008 Feb;20(1):1-5.
  • Viswanathan AN, Hankinson SE, Schernhammer ES.
    Night shift work and the risk of endometrial cancer.
    Cancer Res. 2007 Nov 1;67(21):10618-22.
  • Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, P÷tter R.
    Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours.
    Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):491-8.
  • Holloway CL, Russell AH, Muto M, Albert M, Viswanathan AN.
    Synovial cell sarcoma of the vulva: multimodality treatment incorporating preoperative external-beam radiation, hemivulvectomy, flap reconstruction, interstitial brachytherapy, and chemotherapy.
    Gynecol Oncol. 2007 Jan;104(1):253-6.
  • Stewart AJ, Viswanathan AN.
    Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer.
    Cancer. 2006 Sep 1;107(5):908-15. Review.
  • Viswanathan AN, Cormack R, Holloway CL, Tanaka C, O'farrell D, Devlin PM, Tempany C.
    Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer.
    Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):91-9.
  • Xiong L, Viswanathan A, Stewart AJ, Haker S, Tempany CM, Chin LM, Cormack RA.
    Deformable structure registration of bladder through surface mapping.
    Med Phys. 2006 Jun;33(6):1848-56.
  • Viswanathan AN, Lee H, Hanson E, Berkowitz RS, Crum CP.
    Influence of margin status and radiation on recurrence after radical hysterectomy in stage IB cervical cancer.
    Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1501-7.
  • Viswanathan AN, Feskanich D, De Vivo I, Hunter DJ, Barbieri RL, Rosner B, Colditz GA, Hankinson SE.
    Smoking and the risk of endometrial cancer: results from the Nurses' Health Study.
    Int J Cancer. 2005 May 10;114(6):996-1001.
  • Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ.
    Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.
    Gynecol Oncol. 2004 Apr;93(1):27-33.
  • Viswanathan AN, Grier HE, Litman HJ, Perez-Atayde A, Tarbell NJ, Neuberg D, Shamberger RC, Marcus KJ.
    Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.
    Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1208-14.
  • Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH.
    Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.
    J Clin Oncol. 2001 Aug 15;19(16):3685-91.
  • Arbiser JL, Karalis K, Viswanathan A, Koike C, Anand-Apte B, Flynn E, Zetter B, Majzoub JA.
    Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin.
    J Invest Dermatol. 1999 Nov;113(5):838-42.
  • Anand-Apte B, Zetter BR, Viswanathan A, Qiu RG, Chen J, Ruggieri R, Symons M.
    Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the Rac and extracellular signal-regulated kinase pathways.
    J Biol Chem. 1997 Dec 5;272(49):30688-92.